GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, …
GARDASIL 9 is a vaccine indicated in females 9 through 45 years of age for the prevention of cervical, vulvar, vaginal, anal, oropharyngeal and other head and neck cancers caused by human papillomavirus (HPV) Types 16, 18, 31, 33, 45, 52, and 58; cervical, vulvar, vaginal, and anal precancerous or dysplastic lesions caused by HPV Types 6, 11, 16...
FDA Approves Merck's HPV Vaccine, GARDASIL®9, to Prevent …
Dec 11, 2014 · GARDASIL 9 includes the greatest number of HPV types in any available HPV vaccine Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA)
GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, …
GARDASIL 9 helps protect individuals ages 9 to 45 against the following diseases caused by 9 types of HPV: cervical, vaginal, and vulvar cancers in females, anal cancer, certain head and neck cancers, such as throat and back of mouth cancers and genital warts in both males and females.
Gardasil | FDA - U.S. Food and Drug Administration
Tradename: Gardasil Manufacturer: Merck & Co., Inc. Indications: Prevention of vulvar and vaginal cancer
GARDASIL® is a vaccine indicated in girls and women 9 through26 years of age for the prevention of the following diseases caused by Human Papillomavirus (HPV) types included in the vaccine:
Merck Announces Plans to Conduct Clinical Trials of a Novel ...
Mar 13, 2024 · In response to calls from scientific leaders for more clinical data concerning alternative dosing regimens for GARDASIL 9, Merck, pending regulatory input, plans to conduct two prospective clinical trials, one in females (16-26 …
GARDASIL 9 | FDA - U.S. Food and Drug Administration
Mar 15, 2024 · Product approval information for Human Papillomavirus 9-valent Vaccine, Recombinant also known as Gardasil 9.
Merck Announces Positive Top-line Results from Phase 3 Trial …
Sep 11, 2024 · GARDASIL 9 is a vaccine indicated in females 9 through 45 years of age for the prevention of cervical, vulvar, vaginal, anal, oropharyngeal and other head and neck cancers caused by human papillomavirus (HPV) Types 16, 18, 31, 33, 45, 52, and 58; cervical, vulvar, vaginal, and anal precancerous or dysplastic lesions caused by HPV Types 6, 11, 16...
Gardasil - Wikipedia
Gardasil is an HPV vaccine for use in the prevention of certain strains of human papillomavirus (HPV). [10] [7] [8] [9] [11] It was developed by Merck & Co. [12] High-risk human papilloma virus (hr-HPV) genital infection is the most common sexually transmitted infection among women. [13]The HPV strains that Gardasil protects against are …
R.F.K. Jr. Would Keep Stake in HPV Vaccine Suit if Confirmed
2 days ago · Kennedy’s Stake in HPV Vaccine Suit: Robert F. Kennedy Jr., Trump’s pick to be health secretary, is keeping his financial stake in major litigation against Merck over a widely used vaccine ...
- Some results have been removed